Nuveen Asset Management’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $2.73M | Sell |
206,947
-128,533
| -38% | -$1.69M | ﹤0.01% | 2253 |
|
|
2024
Q3 | $14.7M | Buy |
335,480
+142,351
| +74% | +$6.25M | ﹤0.01% | 1379 |
|
|
2024
Q2 | $2.08M | Sell |
193,129
-18,801
| -9% | -$202K | ﹤0.01% | 2377 |
|
|
2024
Q1 | $3.16M | Buy |
211,930
+21,194
| +11% | +$316K | ﹤0.01% | 2182 |
|
|
2023
Q4 | $3.45M | Sell |
190,736
-18,807
| -9% | -$341K | ﹤0.01% | 2153 |
|
|
2023
Q3 | $3.63M | Buy |
209,543
+655
| +0.3% | +$11.4K | ﹤0.01% | 2027 |
|
|
2023
Q2 | $3.79M | Buy |
208,888
+160,728
| +334% | +$2.91M | ﹤0.01% | 2049 |
|
|
2023
Q1 | $1.28M | Buy |
48,160
+4,938
| +11% | +$131K | ﹤0.01% | 2513 |
|
|
2022
Q4 | $835K | Buy |
+43,222
| New | +$835K | ﹤0.01% | 2751 |
|
|
2022
Q2 | – | Sell |
-81,824
| Closed | -$619K | – | 3362 |
|
|
2022
Q1 | $619K | Sell |
81,824
-7,122
| -8% | -$53.9K | ﹤0.01% | 2952 |
|
|
2021
Q4 | $1.2M | Sell |
88,946
-4,180
| -4% | -$56.4K | ﹤0.01% | 2794 |
|
|
2021
Q3 | $1.57M | Sell |
93,126
-16,811
| -15% | -$284K | ﹤0.01% | 2787 |
|
|
2021
Q2 | $3.2M | Buy |
109,937
+29,660
| +37% | +$864K | ﹤0.01% | 2482 |
|
|
2021
Q1 | $3.16M | Buy |
80,277
+57,172
| +247% | +$2.25M | ﹤0.01% | 2397 |
|
|
2020
Q4 | $525K | Hold |
23,105
| – | – | ﹤0.01% | 3032 |
|
|
2020
Q3 | $523K | Buy |
+23,105
| New | +$523K | ﹤0.01% | 2941 |
|